.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fish and Richardson
Teva
Boehringer Ingelheim
Covington
Harvard Business School
McKesson
Argus Health
Daiichi Sankyo
Baxter

Generated: June 29, 2017

DrugPatentWatch Database Preview

HYPAQUE Drug Profile

« Back to Dashboard

What is the patent landscape for Hypaque, and when can generic versions of Hypaque launch?

Hypaque is a drug marketed by Ge Healthcare and is included in five NDAs.

The generic ingredient in HYPAQUE is diatrizoate meglumine; diatrizoate sodium. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.

Summary for Tradename: HYPAQUE

Patents:0
Applicants:1
NDAs:5
Bulk Api Vendors: see list81
Clinical Trials: see list3
Patent Applications: see list2,731
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYPAQUE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
HYPAQUE
diatrizoate meglumine
INJECTABLE;INJECTION016403-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE SODIUM 20%
diatrizoate sodium
SOLUTION;URETERAL009561-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE
diatrizoate sodium
INJECTABLE;INJECTION009561-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE-76
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION086505-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE
diatrizoate meglumine
INJECTABLE;INJECTION016403-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Daiichi Sankyo
Fish and Richardson
Federal Trade Commission
AstraZeneca
Dow
Boehringer Ingelheim
Cerilliant
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot